Next-Generation Antibody Therapeutics Market is expected to Boom in Coming Years

1. Boom Predicted in Next-Generation Antibody Therapeutics Market in Future 1 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

2. The global next-generation antibody therapeutics market is set to exhibit substantial growth in the coming years. The prominent factors driving the expansion of the market are the rapid technological advancements, the rising incidence of cancer, and the surging number of collaborations among various market players in order to develop next-generation antibody therapeutics. In addition to this, the rapidly improving infrastructure for life sciences research is massively boosting the advancement of the market across the globe. Receive Sample Pages of this Report: https://www.psmarketresearch.com/market-analysis/next-generation- antibody-market/report-sample The development of antibody drug conjugates (ADCs), bispecific antibodies (BsAbs), and glycoengineered antibodies has augmented the application areas of antibody therapeutics. ADCs are more effective and safer than the conventionally used antibodies in cancer treatment, as they are made by combining a biologically active cytotoxic drug and a monoclonal antibody for targeting tumor cells. This helps overcome the existing challenges of limited applications of monoclonal antibody therapeutics. Therefore, it can be said that rapid technological advancements are fueling product innovations. This is, in turn, propelling the growth of the next-generation antibody therapeutics market. Based on technology, the market is classified into ADCs, BsAbs, biosimilar antibody (Ab) products, Fc engineered antibodies, and antibody fragments and antibody-like proteins (AF & ALPs). Out of these, the ADCs category is predicted to record the highest growth in the market in the future years. The Fc engineered antibodies category is predicted to exhibit the fastest growth in the market in the forthcoming years. When therapeutic area is taken into consideration, the market is divided into oncology and autoimmune/inflammatory categories. Between these, the oncology category is predicted to hold huge revenue share in the market during the next few years. On the other hand, the autoimmune/inflammatory category will exhibit rapid expansion in the global market in the years to come, as per the estimates of P&S Intelligence, a market research company based in India. One of the major trends witnessed in the next-generation antibody therapeutics market is the rising popularity of the ADC technology. The cytotoxic characteristic nature of antibodies is predicted to be very beneficia in chemotherapy. This characteristic is regulated and expressed by the ADC technology for increased specificity and efficacy. Due to the high efficiency of ADCs, biotechnology and pharmaceutical firms all over the world are heavily focusing on developing ADCs. 2 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

3. Globally, the next-generation antibody therapeutics market is predicted to register the highest growth in North America in the coming years. The market will demonstrate a CAGR of more than 40.0% in this region during the coming years. The factors driving the progress of the market in this region are the existence of various established players and a well-developed life sciences research infrastructure, the rising incidence of chronic diseases, and the increasing implementation of favorable government policies regarding antibody therapeutics research. Hence, it can be concluded from the above paragraphs that the market will grow substantially in the coming years, mainly because of the rising incidence of various chronic health conditions and the rapid technological advancements in healthcare and antibody research around the world. GLOBAL NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET  By Therapeutic Area – Oncology and Autoimmune/Inflammatory By Technology – Antibody Drug Conjugates (ADCs), Bispecific Antibodies (BsAbs), Fc Engineered Antibodies, Antibody Fragments and Antibody –like Proteins (AF & ALPs), and Biosimilar Antibody (Ab) Products By Region – North America, Europe, Asia-Pacific and Rest of the World GLOBAL NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET, BY THERAPEUTIC AREA    Oncology market breakdown by region Autoimmune/Inflammatory market breakdown by region GLOBAL NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET, BY TECHNOLOGY   Antibody drug conjugates (ADCs) market breakdown by region  Bispecific antibodies (BsAbs) market breakdown by region Fc engineered antibodies market breakdown by region Antibody fragments and antibody-like proteins (AF &ALPs) market breakdown by region Biosimilar antibody (Ab) products market breakdown by region GLOBAL NEXT-GENERATION ANTIBODY THERAPEUTICS MARKET, BY GEOGRAPHY    North America Next-Generation Antibody Therapeutics Market  North America next-generation antibody therapeutics market breakdown by country – The U.S. and Rest of North America 3 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

4. North America next-generation antibody therapeutics market breakdown by therapeutic area North America next-generation antibody therapeutics market breakdown by technology Europe Next-Generation Antibody Therapeutics Market    Europe next-generation antibody therapeutics market breakdown by country – Germany, the U.K., France, and Rest of Europe Europe next-generation antibody therapeutics market breakdown by therapeutic area Europe next-generation antibody therapeutics market breakdown by technology Asia-Pacific Next-Generation Antibody Therapeutics Market    Asia-Pacific next-generation antibody therapeutics market breakdown by country – Japan and Rest of Asia-Pacific  Asia-Pacific next-generation antibody therapeutics market breakdown by therapeutic area Asia-Pacific next-generation antibody therapeutics market breakdown by technology Rest of the World Next-Generation Antibody Therapeutics Market   Rest of the World next-generation antibody therapeutics market breakdown by therapeutic area Rest of the World next-generation antibody therapeutics market breakdown by technology .  4 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved

5. Disclaimer: P&S Intelligence always keeps its customers’ interests at the core while carrying out research activities. P&S Intelligence ensures the reliability and accuracy of information and data provided in its market research publications. However, the information in publications is subject to fluctuations, as it is based on primary interviews of officials from various companies or organizations. P&S Intelligence is not responsible for any incorrect data provided by the key industry players of the concerned domain. The information or analysis in P&S Intelligence publications represents opinions based on research and should not be interpreted as statements of fact. Information in this report was believed to be correct at the time of publication, but cannot be guaranteed. P&S Intelligence does not endorse any product, service, or vendor depicted in its research publications. All intellectual properties, including trademarks and copyrights, belong to their respective owners and may be protected by copyright. Under no circumstance can these be reproduced in any form without prior written agreement of their owners. An order for market research report is intended for internal use of the company only and not for disclosure to third parties or any other publication in general. No service, report, or part thereof provided by P&S Intelligence can be reproduced, republished, resold, revealed, distributed, circulated, or sublicensed in any medium or form now realized or hereafter become realized, including but not limited to, all forms of optical-based media, magnetic, electronic, or digital, without a written permission from Prescient & Strategic Intelligence Pvt. Kindly write to: enquiry@psmarketresearch.com B-13, Sector – 2, Noida, U.P. – 201301, INDIA Contact No: +91 120 4541 337 US/Canada Toll-Free: 1-888-778-7886 5 © Prescient & Strategic (P&S) Intelligence Pvt. Ltd. All rights reserved